Condor Capital Management Cyclacel Pharmaceuticals, Inc. Transaction History

Condor Capital Management

  • $1.09 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$0.54 - $21.75 $5,400 - $217,500
10,000 New
10,000 $6,000

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $4.51M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Condor Capital Management Portfolio

Follow Condor Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Condor Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email